Topic summary

Travelling with an injectable: documentation and practicalities

Access › International NHS personal import EMA MHRA

This is a generated summary. It shows the 6 most-liked posts from a topic of 43, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

j.sandvikTL224 Dec 2025#3

a.thorne, post #2: A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site. The uncertainty is in the assumption, not in the calculation. Go to post

This follows the opening post rather than contradicting it.

Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.

A partial answer, offered because a partial answer beats none.

24 likes in reply to #2 7mo

RidgewayTL3Regular1 Mar 2026 · edited#13

z.adeyemi, post #12: Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one. I have changed my mind on this once already, so take it as current rather than settled. Go to post

Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of which are on the packaging.

25 likes in reply to #12 5mo

GDashwoodTL3Regular24 Apr 2026#23

SHermansen, post #8: Post #6 and I disagree about the size of the effect, not about the direction. Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago. This is the sort of thing the wiki should carry and currently does not. Go to post

Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one.

30 likes in reply to #8 3mo

g.haalandTL3Regular14 May 2026#27

Rodrigues, post #6: Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union; tirzepatide approved in some but not all; retatrutide approved nowhere yet (ongoing trials). Go to post

Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question.

A single observation, in a thread that deserves better than single observations.

22 likes in reply to #6 2mo

citation_indexTL2Member14 Jul 2026#40

s.ostergaard, post #9: Confirming post #8 from a second method, which matters more than confirming it from a second person. Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question. I have deliberately not rounded that, because the rounding is where the argument starts. Go to post

Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position.

22 likes in reply to #9 14d

s.radichTL227 Jul 2026#43

Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union; tirzepatide approved in some but not all; retatrutide approved nowhere yet (ongoing trials).

Noting that the question and the thing people usually mean by it are different.

25 likes 1d

Read the full topic (43 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
What changed in 2026, by region Access › International EMA NHS personal import Solved What changed in 2026, by region — that is the question, and I have not found it answered plainly anywhere I have looked. Documenting an access outcome, dated, because everything in this category expires. As…	+110	122	1.4k	18mo
Prescription portability between countries Access › International personal import MHRA telehealth EMA Wiki Prescription portability between countries — setting out what I have, and where I think it stops being reliable. Asking about prescription portability between countries directly, because I have read four…	+104	114	6.1k	3h
Availability by country, dated, with primary sources Access › International EMA MHRA telehealth personal import On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As…	+72	81	6.9k	8mo
Personal import allowances, compared — a second dataset Access › International personal import telehealth MHRA EMA Wiki Personal import allowances, compared — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Personal import allowances. It is mine, it is…	+124	132	9.2k	2mo
Second pass at: Cross-border purchase within the EU: the actual rules Access › International NHS personal import EMA telehealth Posting this under the heading it deserves: Second pass at: Cross-border purchase within the EU: the actual rules Everything below is what sits behind that. The question about Cross-border purchase within…	+135	139	8.7k	16mo

Related topics — sharing the tags NHS, personal import, EMA

Topic	Participants	Replies	Views	Activity
EMA product information as a primary source Regional › European Union personal import formulary EMA Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Something about EMA product information does not reconcile and I would like a…	+70	74	7k	8mo
[2026 update] Availability by country, dated, with primary sources Access › International MHRA NHS telehealth personal import On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As…	+40	45	14k	4mo
Second pass at: Reimbursement variation across member states Regional › European Union personal import formulary cost per milligram EMA On the subject in the title: Second pass at: Reimbursement variation across member states Working notes rather than a conclusion. The question about Reimbursement variation across member states that I…	+23	28	45k	21mo
Personal import allowances, compared Access › International EMA MHRA telehealth personal import Wiki On the subject in the title: Personal import allowances, compared Working notes rather than a conclusion. I have spent a fortnight trying to pin personal import allowances down and I want to set out where I…	+5	9	3.2k	7mo
Research-use-only labelling: what it means and what it does not Sourcing › Regulatory compounding research use only EMA FDA Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that. A labelling question, and I would like the answer to be…	+100	110	37k	5mo